Long-term trends in hepatitis A incidence following the inclusion of Hepatitis A vaccine in the routine nationwide immunization program

Journal of Viral Hepatitis

Volumn 15, Issue SUPPL.2, 2008, Pages 62-65

  Chodick, G ^a,c   Heymann, A D ^a   Ashkenazi, S ^a,b   Kokia, E ^a   Shalev, V ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^c MACCABI HEALTHCARE SERVICES   (Israel)

Author keywords

Epidemiology; Hepatitis A; Immunization; Israel

Indexed keywords

HEPATITIS A VACCINE;

ADOLESCENT; ADULT; CHILD; CONFERENCE PAPER; DATA BASE; HEALTH MAINTENANCE ORGANIZATION; HEALTH PROGRAM; HEPATITIS A; HUMAN; IMMUNIZATION; INCIDENCE; INFECTION PREVENTION; ISRAEL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK REDUCTION; SINGLE DRUG DOSE; VACCINATION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS A; HEPATITIS A VACCINES; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; ISRAEL; MALE; VACCINATION; YOUNG ADULT;

EID: 50649106854     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2008.01032.x     Document Type: Conference Paper

References (22)

1. World Health Organization. Hepatitis A. WHO/CDS/CSR/EDC/2000.7. Geneva, Switzerland : World Health Organization, 2000 : 1 41. Available from: http://www.who.int/csr/disease/hepatitis/HepatitisA_whocdscsredc2000_7.pdf (Last accessed 14 July 2008).
2. Centers for Disease Control. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1996 45 : 1 30.
3. Green M, Block C, Slater P. Rise in the incidence of viral hepatitis in Israel despite improved socioeconomic conditions. Rev Infect Dis 1989 11 : 464 469.
4. Bell B, Andersen D, Feinstone S. Hepatitis A virus. In : Mandell G, Bennett J, Dolin R, eds. Mandell, Douglas, and Bennett's: Principles and Practice of Infectious Diseases, 6th edn. Philadelphia, PA : Churchill Livingstone, 2005 : 2162 2180.
5. Dagan R, Leventhal A, Anis E, Slater P, Ashur Y, Shouval D. Incidence of hepatitis A in Israel following universal immunization of toddlers. JAMA 2005 294 : 202 210.
6. Chodick G, Green M, Heymann A, Rosenmann L, Shalev V. The shifting epidemiology of hepatitis A following routine childhood immunization program in Israel. Prev Med 2007 45 : 386 391.
7. Reisler D, Brachot D, Mosley J. Viral hepatitis in Israel: morbidity and mortality data. Am J Epidemiol 1970 92 : 62 72.
8. Hanna JN, Hills SL, Humphreys JL. Impact of hepatitis A vaccination of Indigenous children on notifications of hepatitis A in north Queensland. Med J Aust 2004 181 : 482 485.
9. Welty TK, Darling K, Dye S et al. Guidelines for prevention and control of hepatitis A in American Indian and Alaska Native communities. S D J Med 1996 49 : 317 322.
10. Bialek SR, Thoroughman DA, Hu D et al. Hepatitis A incidence and hepatitis a vaccination among American Indians and Alaska Natives, 1990-2001. Am J Public Health 2004 94 : 996 1001.
11. McMahon BJ, Beller M, Williams J, Schloss M, Tanttila H, Bulkow L. A program to control an outbreak of hepatitis A in Alaska by using an inactivated hepatitis A vaccine. Arch Pediatr Adolesc Med 1996 150 : 733 739.
12. Lopalco P, Salleras L, Barbuti S et al. Hepatitis A and B in children and adolescents - what can we learn from Puglia (Italy) and Catalonia (Spain)? Vaccine 2000 19 : 470 474.
13. Averhoff F, Shapiro CN, Bell BP et al. Control of hepatitis A through routine vaccination of children. JAMA 2001 286 (23 2968 2973.
14. Sonder G, Bovee L, Baayen T, Coutinho R, van den Hoek J. Effectiveness of a hepatitis A vaccination program for migrant children in Amsterdam, The Netherlands (1992-2004). Vaccine 2006 24 : 4962 4968.
15. Wasley A, Samandari T, Bell B. Incidence of hepatitis A in the United States in the era of vaccination. JAMA 2005 294 : 194 201.
16. Zhou F, Shefer A, Weinbaum C, McCauley M, Kong Y. Impact of hepatitis A vaccination on health care utilization in the United States, 1996-2004. Vaccine 2007 25 : 3581 3587.
17. Samandari T, Bell B, Armstrong G. Quantifying the impact of hepatitis A immunization in the United States, 1995-2001. Vaccine 2004 22 : 4342 4350.
18. Gdalevich M, Grotto I, Mandel Y, Mimouni D, Shemer J, Ashkenazi I. Hepatitis A antibody prevalence among young adults in Israel - the decline continues. Epidemiol Infect 1998 121 : 477 479.
19. Belmaker I, Dukhan L, Yosef Y, Leventhal A, Dagan R. Elimination of hepatitis A infection outbreaks in day care and school settings in southern Israel after introduction of the national universal toddler hepatitis A immunization program. Pediatr Infect Dis J 2007 26 : 36 40.
20. Lerman Y, Chodik G, Aloni H, Ashkenazi S. How valid is the official data from the Health Department on reported morbidity in Israel? Hepatitis A as an example. Harefuah 1999 136 : 441 445.
21. Swartz T, Levin J, Ben-Porat E. Epidemiology of hepatitis A in Israel. Monogr Virol 1984 15 : 341 345.
22. Kark J, Camhy N, Shany S. Reduction in hepatitis A antibody prevalence among young adults in Israel. Public Health Rev 1992-93 20 : 31 40.